<i>Aspergillus</i>Galactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients

2002391 citationsJournal Article

Authors

Raoul Herbrecht · Institut d’Hématologie et d’Oncologie Pédiatrique

Valérie Letscher‐Bru · Institut d’Hématologie et d’Oncologie Pédiatrique

Corina Oprea · Institut d’Hématologie et d’Oncologie Pédiatrique

Bruno Lioure · Institut d’Hématologie et d’Oncologie Pédiatrique

J. Waller · Institut d’Hématologie et d’Oncologie Pédiatrique

France Campos · Institut d’Hématologie et d’Oncologie Pédiatrique

Abstract

Galactomannan ELISA seems less sensitive than previously described, and sensitivity can be further reduced by the presence of anti-Aspergillus antibodies. A new cutoff value for the ELISA of 0.700 is proposed for non-allo-HSCT adults.

Topics & Keywords

Antifungal resistance and susceptibility Fungal Infections and Studies Pneumocystis jirovecii pneumonia detection and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 20, Issue 7, pp. 1898-1906

DOI: 10.1200/jco.2002.07.004

Field-Weighted Citation Impact: 13.94